Skip to site menu Skip to page content

Daily Newsletter

11 August 2023

Daily Newsletter

11 August 2023

IHH Healthcare signs agreement to acquire Bedrock Healthcare

BHSB will construct a new 200-bed tertiary hospital on vacant land in central Kuching.

August 11 2023

IHH Healthcare’s indirect wholly owned subsidiary Pantai Holdings has signed an agreement to acquire Bedrock Healthcare (BHSB) for RM245m ($72.4m) on a cash-free, debt-free basis.

Pantai signed a share purchase agreement with Saravita Holdings and nine individual founders to acquire the entire equity interest in BHSB.

Through its wholly owned subsidiaries, BHSB owns the 82-bed Timberland Medical Centre in Kuching, Sarawakand, Malaysia.

Timberland Medical Centre provides various surgical, medical, and hospital services, including hepatology, orthopaedic, gastroenterology, cardiology, urology, nephrology, oncology, and general and orthopaedic surgery.

On vacant land in central Kuching, BHSB plans to construct a new 200-bed tertiary hospital.

IHH Healthcare group chief strategy and business development officer Ashok Pandit said: “The acquisition and new development will strengthen IHH’s position as a leading provider of quality and comprehensive care across Malaysia.

“The two assets will complement our cluster strategy for East Malaysia and bring the total IHH bed capacity in East Malaysia to almost 500 in the future.”

Subject to regulatory clearances and the satisfaction of conditions, the proposed acquisition is anticipated to be completed by the first half of next year, and operations will be carried out without any interruptions.

IHH Healthcare Malaysia CEO Jean-François Naa said: “The proposed acquisition will allow IHH to strengthen its position in Sarawak by scaling up Timberland’s operations via a new 200-bed tertiary hospital to be constructed in central Kuching, with a further investment of approximately RM400m ($87.4m), to serve the local needs, as well as the fast-growing medical tourism market from Indonesia.”

Healthcare companies are hesitant to invest in the metaverse

The COVID-19 pandemic pushed the healthcare industry to rapid digitalization. Increased use of telehealth, telepresence systems, remote diagnostics, predictive AI, and wearable technology is changing how healthcare is delivered and improving patient outcomes. Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment of psychological and neurological disorders. In the pharma and medical devices industries, AR, VR, and AI are rapidly accelerating drug discovery and manufacturing and generating supply chain efficiencies. New digital opportunities will look to build upon disruptive technologies. However, affordability is a limiting factor to widespread adoption. Per GlobalData estimates, the metaverse market is expected to grow at a CAGR of more than 33% between 2023 and 2030. Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close